Key result
Subject-specific non-linear models incorporating heart rate and LV pressure improve contractility correction by ~14%.
Correcting cardiac contractility for heart rate and systolic LV pressure using subject-specific, non-linear models may enhance data interpretation in non-clinical drug safety assessments.
Answers are grounded in this paper and cite their sources.
May refine contractility assessment in preclinical safety studies; leaves open translation to clinical or regulatory use.
QT has a long history of heart rate (HR) correction but limited investigations have been undertaken to assess the impact of cardiovascular parameters on left ventricular (LV) contractility in drug safety testing. Cardiac contractility is affected by preload (Cyon-Frank-Starling law), afterload (Anrep effect) and HR (Bowditch effect). We evaluated multi-parameter correction methods to help with dP/dtmax interpretation. Modeling was undertaken using data from dogs in single or double 4 × 4 Latin square studies. Correction models (16 fitting formulas × 2 modeling approaches (universal and individualized) × 2 correction approaches (linear or proportional)) were evaluated. 3D/2D cloud analysis of the beat-to-beat data for the control, pimobendan, and either itraconazole or atenolol groups were used to evaluate correlations between parameters and derive an optimal correction method. Cardiac contractility (i.e., dP/dtmax) was best correlated to HR and systolic LV pressure with a correlation coefficient of 0.8. In decreasing order, dP/dtmin, mean arterial blood pressure (BP), systolic BP, diastolic BP, arterial pulse pressure and LV end diastolic pressure (LVEDP) showed a reduced correlation to dP/dtmax. Subject-specific models improved the correction by up to 14% when compared to universal correction models. The non-linear correction model was superior to the linear model. Results suggest that the optimal correction formula for dP/dtmax would be subject-specific, non-linear and would include HR and LV systolic pressure. Correcting contractility for HR and systolic LV pressure may enhance data interpretation in non-clinical drug safety assessments. Similar correction methods could be evaluated for other species used in safety pharmacology.
No takes yet. Share an insight, caveat, or question.
Boulay et al. (2017) studied Cardiac contractility assessment. Subject-specific, non-linear correction models vs. Universal and linear correction models was evaluated on Correlation to dP/dtmax (correlation coefficient 0.8). Subject-specific, non-linear correction models incorporating heart rate and LV systolic pressure best correlated with cardiac contractility and improved correction by up to 14%.
Synapse has enriched 10 related papers. Consider them for comparative context: